Article(id=1330233261932000127, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233261445460863, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.11.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1694534400000, receivedDateStr=2023-09-13, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795081924182, onlineDateStr=2026-11-19, pubDate=1699545600000, pubDateStr=2023-11-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795081924182, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795081924182, creator=13701087609, updateTime=1795081924182, updator=13701087609, issue=Issue{id=1330233261445460863, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='11', pageStart='1535', pageEnd='1686', issueExtLink='null', onlineDate='null', pubDate='1699545600000', pubDateStr='2023-11-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795081924067, creator='13701087609', updateTime=1795082602211, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330236106353782847, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233261445460863, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330236106353782848, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233261445460863, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1535, endPage=1544, ext={EN=ArticleExt(id=1330233262150103936, articleId=1330233261932000127, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Recent Progress in the Synthesis of Tucatinib, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Tucatinib(1) is an oral inhibitor of HER2 for clinical treatment of HER2- positive breast cancers. In this paper, the synthesis methods of 1 and its key intermediate 4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline(2) are reviewed, and the advantages and disadvantages of each synthetic route are discussed. This review is beneficial to the future process research of tucatinib.

, authors=Guanglong BAO, Honggang WANG, Naihua ZHANG, Yangguang XIANG, Guimin ZHANG*, authorsList=Guanglong BAO, Honggang WANG, Naihua ZHANG, Yangguang XIANG, Guimin ZHANG, authorCompany=null, correspAuthors=Guimin ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330233263949460353, articleId=1330233261932000127, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=妥卡替尼的合成研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

妥卡替尼(1)是一种可口服的人类表皮生长因子受体酪氨酸激酶(HER2)抑制剂,临床上主要用于治疗HER2阳性乳腺癌。文章分别对1及其重要中间体4-([1,2,4]三唑并[1,5-a]吡啶-7-氧基)-3-甲基苯胺(2)的合成方法进行了总结、概括,并对各路线进行了简要评述,为该药物的合成工艺研究提供有益参考。

, authors=鲍广龙, 王洪刚, 张乃华, 相阳光, 张贵民*, authorsList=鲍广龙, 王洪刚, 张乃华, 相阳光, 张贵民, authorCompany=null, correspAuthors=张贵民, authorNote=

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

, correspAuthorsNote=
张贵民(1969—),男,研究员,从事药物研发及工程化研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=sm6xHs96FAOhnh1ls8jUQw==, magXml=CMyBZCb9jbK48EYR2tRSZw==, pdfUrl=null, pdf=3WGLJ6Zei/5vMEUPS3bCWQ==, pdfFileSize=2714048, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=mbNyn1IlM+IVAkD9htDWeQ==, mapNumber=null, fund=null)}, authors=[Author(id=1330233264201118598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233264280810376, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264201118598, language=EN, stringName=Guanglong BAO, firstName=Guanglong, middleName=null, lastName=BAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233264339530633, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264201118598, language=CN, stringName=鲍广龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio={"content":"

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

"}, bioImg=null, bioContent=

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1330233264394056587, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233264456971149, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264394056587, language=EN, stringName=Honggang WANG, firstName=Honggang, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233264515691406, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264394056587, language=CN, stringName=王洪刚, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1330233264578605968, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233264654103442, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264578605968, language=EN, stringName=Naihua ZHANG, firstName=Naihua, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233264733795219, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264578605968, language=CN, stringName=张乃华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1330233264796709781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233264859624343, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264796709781, language=EN, stringName=Yangguang XIANG, firstName=Yangguang, middleName=null, lastName=XIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233264930927512, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264796709781, language=CN, stringName=相阳光, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1330233264993842074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lunanzhangguimin@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233265060950940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264993842074, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233265136448413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264993842074, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])])], keywords=[Keyword(id=1330233265249694622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, language=EN, orderNo=1, keyword=tucatinib), Keyword(id=1330233265329386399, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, language=EN, orderNo=2, keyword=anti-breast cancer), Keyword(id=1330233265430049696, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, language=EN, orderNo=3, keyword=synthesis), Keyword(id=1330233265505547169, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, language=EN, orderNo=4, keyword=review), Keyword(id=1330233265564267426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, language=CN, orderNo=1, keyword=妥卡替尼), Keyword(id=1330233265635570595, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, language=CN, orderNo=2, keyword=抗乳腺癌), Keyword(id=1330233265694290852, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, language=CN, orderNo=3, keyword=合成), Keyword(id=1330233265753011109, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, language=CN, orderNo=4, keyword=综述)], refs=[Reference(id=1330233265832702886, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=刘建宇,许永男.妥卡替尼(Tucatinib,Tukysa)[J].中国药物化学杂志,2021,31(3):246., articleTitle=null, refAbstract=null), Reference(id=1330233265895617447, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=钱小明,丁芹,肖小荣,等.一种图卡替尼中间体的制备方法:中国,114685493A [P].2022-07-01., articleTitle=null, refAbstract=null), Reference(id=1330233265966920616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=阿雷生物药品公司.作为ERBBI型受体酪氨酸激酶抑制剂用于治疗增殖性疾病的N4-苯基-喹唑啉-4-胺衍生物和相关化合物: 中国, 101356171A [P].2009-01-28., articleTitle=null, refAbstract=null), Reference(id=1330233266059195305, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=赵攀峰,钟强,姜福元,等.一种图卡替尼中间体的制备方法:中国,114031619A [P].2022-02-11., articleTitle=null, refAbstract=null), Reference(id=1330233266130498474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=尹灵烽,茆勇军,赵智伟,等.Irbinitinib及中间体的制备方法:中国,109942576B [P].2020-09-11., articleTitle=null, refAbstract=null), Reference(id=1330233266210190251, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=YIN L F, MAO Y J, LIU Y W, et al. New synthetic route to tucatinib [J]. Synthesis, 2019, 51(13): 2660-2664., articleTitle=null, refAbstract=null), Reference(id=1330233266289882028, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=尹灵烽.妥卡替尼的合成工艺研究[D].上海:上海工程技术大学硕士学位论文,2020., articleTitle=null, refAbstract=null), Reference(id=1330233266361185198, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=孟春甫.图卡替尼合成工艺研究[D].青岛:青岛科技大学硕士学位论文,2022., articleTitle=null, refAbstract=null), Reference(id=1330233266428294063, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=陈新海,姜奋,陈鑫德,等.作为选择性HER2抑制剂的吡咯并[2,1-f][1,2,4]三嗪类衍生物及其应用:中国,112105618A [P].2020-12-18., articleTitle=null, refAbstract=null), Reference(id=1330233266503791536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=张天军,高军龙.妥卡替尼的合成新工艺[J].山东化工,2020,49(5):25-28., articleTitle=null, refAbstract=null), Reference(id=1330233266570900401, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=唐家邓,王小梅,茆勇军.一种妥卡替尼中间体的制备方法:中国,112898298A [P].2021-06-04., articleTitle=null, refAbstract=null), Reference(id=1330233268206678962, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=LYU Y D, HUANG L L, ZHU X L, et al. A practical alternate synthesis of tucatinib [J]. Org Prep Proced Int,2021, 53(6): 554-561., articleTitle=null, refAbstract=null), Reference(id=1330233268282176435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=范昭泽,黄祥泉,余艳平,等.一种HER2小分子抑制剂图卡替尼的制备方法:中国,114230568A [P].2022-03-25., articleTitle=null, refAbstract=null), Reference(id=1330233268345090996, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=黄加香,刘洋,王巳天,等.妥卡替尼的合成[J].精细化工,2022,39(9):1894-1900., articleTitle=null, refAbstract=null), Reference(id=1330233268500280245, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=李正涛,钟卫,王家秉,等.ERBB受体抑制剂:中国,111587248A [P].2020-08-25., articleTitle=null, refAbstract=null), Reference(id=1330233268559000502, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=范昭泽,黄祥泉,余艳平,等.一种HER2小分子抑制剂图卡替尼的制备工艺:中国,114262327A [P].2022-04-01., articleTitle=null, refAbstract=null), Reference(id=1330233268634497975, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=唐家邓,茆勇军,王小梅.妥卡替尼中间体7-羟基-[1,2,4]-三唑并[1,5-a]吡啶的制备方法:中国,114671867A [P].2022-06-28., articleTitle=null, refAbstract=null), Reference(id=1330233268697412536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=王郁萱,李智,温进富,等.一种图卡替尼及其中间产物的合成方法:中国,111825604A [P].2020-10-27., articleTitle=null, refAbstract=null), Reference(id=1330233268760327097, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=王灿辉,王伟,张钊,等.妥卡替尼关键中间体及其制备方法:中国,114621221A [P].2022-06-14., articleTitle=null, refAbstract=null), Reference(id=1330233268823241658, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=阵列生物制药公司.ErbB2(HER2)抑制剂的固态分散体:中国,103998023A [P].2014-08-20., articleTitle=null, refAbstract=null), Reference(id=1330233268928099259, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=阿雷生物药品公司.脑癌的治疗:中国,104203279A[P].2014-12-10., articleTitle=null, refAbstract=null), Reference(id=1330233268995208124, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=阵列生物制药公司.选择性HERB2抑制剂ARRY-380的多晶型物和含有它们的药物组合物:中国,104011047A[P].2014-08-27., articleTitle=null, refAbstract=null), Reference(id=1330233269079094205, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=张海,钟强,刘志威,等.一种妥卡替尼的制备方法:中国,112159404A [P].2021-01-01., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.11.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.11.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.11.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.11.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1699545600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
妥卡替尼的合成研究进展
鲍广龙 , 王洪刚 , 张乃华 , 相阳光 , 张贵民 *
中国医药工业杂志 | 综述 2023,54(11): 1535-1544
收起
收藏切换
中国医药工业杂志 |综述 2023 , 54 (11) : 1535 -1544
妥卡替尼的合成研究进展
全屏
[Author(id=1330233264201118598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233264280810376, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264201118598, language=EN, stringName=Guanglong BAO, firstName=Guanglong, middleName=null, lastName=BAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233264339530633, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264201118598, language=CN, stringName=鲍广龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio={"content":"

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

"}, bioImg=null, bioContent=

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1330233264394056587, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233264456971149, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264394056587, language=EN, stringName=Honggang WANG, firstName=Honggang, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233264515691406, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264394056587, language=CN, stringName=王洪刚, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1330233264578605968, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233264654103442, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264578605968, language=EN, stringName=Naihua ZHANG, firstName=Naihua, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233264733795219, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264578605968, language=CN, stringName=张乃华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1330233264796709781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233264859624343, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264796709781, language=EN, stringName=Yangguang XIANG, firstName=Yangguang, middleName=null, lastName=XIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233264930927512, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264796709781, language=CN, stringName=相阳光, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1330233264993842074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lunanzhangguimin@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233265060950940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264993842074, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233265136448413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, authorId=1330233264993842074, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233264129815426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, xref=null, ext=[AuthorCompanyExt(id=1330233264134009731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1330233264142398340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233261932000127, companyId=1330233264129815426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])])]
鲍广龙, 王洪刚, 张乃华, 相阳光, 张贵民*
作者信息
  • 鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400
通讯作者:
张贵民(1969—),男,研究员,从事药物研发及工程化研究。E-mail:
作者简介:

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

Recent Progress in the Synthesis of Tucatinib
Guanglong BAO, Honggang WANG, Naihua ZHANG, Yangguang XIANG, Guimin ZHANG*
Affiliations
  • National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400
出版时间: 2023-11-10 doi: 10.16522/j.cnki.cjph.2023.11.001
文章导航
收藏切换

妥卡替尼(1)是一种可口服的人类表皮生长因子受体酪氨酸激酶(HER2)抑制剂,临床上主要用于治疗HER2阳性乳腺癌。文章分别对1及其重要中间体4-([1,2,4]三唑并[1,5-a]吡啶-7-氧基)-3-甲基苯胺(2)的合成方法进行了总结、概括,并对各路线进行了简要评述,为该药物的合成工艺研究提供有益参考。

妥卡替尼  /  抗乳腺癌  /  合成  /  综述

Tucatinib(1) is an oral inhibitor of HER2 for clinical treatment of HER2- positive breast cancers. In this paper, the synthesis methods of 1 and its key intermediate 4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline(2) are reviewed, and the advantages and disadvantages of each synthetic route are discussed. This review is beneficial to the future process research of tucatinib.

tucatinib  /  anti-breast cancer  /  synthesis  /  review
鲍广龙, 王洪刚, 张乃华, 相阳光, 张贵民. 妥卡替尼的合成研究进展. 中国医药工业杂志, 2023 , 54 (11) : 1535 -1544 . DOI: 10.16522/j.cnki.cjph.2023.11.001
Guanglong BAO, Honggang WANG, Naihua ZHANG, Yangguang XIANG, Guimin ZHANG. Recent Progress in the Synthesis of Tucatinib[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (11) : 1535 -1544 . DOI: 10.16522/j.cnki.cjph.2023.11.001

参考文献 引证文献
排序方式:
[1]
刘建宇,许永男.妥卡替尼(Tucatinib,Tukysa)[J].中国药物化学杂志,2021,31(3):246.
[2]
钱小明,丁芹,肖小荣,等.一种图卡替尼中间体的制备方法:中国,114685493A [P].2022-07-01.
[3]
阿雷生物药品公司.作为ERBBI型受体酪氨酸激酶抑制剂用于治疗增殖性疾病的N4-苯基-喹唑啉-4-胺衍生物和相关化合物: 中国, 101356171A [P].2009-01-28.
[4]
赵攀峰,钟强,姜福元,等.一种图卡替尼中间体的制备方法:中国,114031619A [P].2022-02-11.
[5]
尹灵烽,茆勇军,赵智伟,等.Irbinitinib及中间体的制备方法:中国,109942576B [P].2020-09-11.
[6]
YIN L F, MAO Y J, LIU Y W, et al. New synthetic route to tucatinib [J]. Synthesis, 2019, 51(13): 2660-2664.
[7]
尹灵烽.妥卡替尼的合成工艺研究[D].上海:上海工程技术大学硕士学位论文,2020.
[8]
孟春甫.图卡替尼合成工艺研究[D].青岛:青岛科技大学硕士学位论文,2022.
[9]
陈新海,姜奋,陈鑫德,等.作为选择性HER2抑制剂的吡咯并[2,1-f][1,2,4]三嗪类衍生物及其应用:中国,112105618A [P].2020-12-18.
[10]
张天军,高军龙.妥卡替尼的合成新工艺[J].山东化工,2020,49(5):25-28.
[11]
唐家邓,王小梅,茆勇军.一种妥卡替尼中间体的制备方法:中国,112898298A [P].2021-06-04.
[12]
LYU Y D, HUANG L L, ZHU X L, et al. A practical alternate synthesis of tucatinib [J]. Org Prep Proced Int,2021, 53(6): 554-561.
[13]
范昭泽,黄祥泉,余艳平,等.一种HER2小分子抑制剂图卡替尼的制备方法:中国,114230568A [P].2022-03-25.
[14]
黄加香,刘洋,王巳天,等.妥卡替尼的合成[J].精细化工,2022,39(9):1894-1900.
[15]
李正涛,钟卫,王家秉,等.ERBB受体抑制剂:中国,111587248A [P].2020-08-25.
[16]
范昭泽,黄祥泉,余艳平,等.一种HER2小分子抑制剂图卡替尼的制备工艺:中国,114262327A [P].2022-04-01.
[17]
唐家邓,茆勇军,王小梅.妥卡替尼中间体7-羟基-[1,2,4]-三唑并[1,5-a]吡啶的制备方法:中国,114671867A [P].2022-06-28.
[18]
王郁萱,李智,温进富,等.一种图卡替尼及其中间产物的合成方法:中国,111825604A [P].2020-10-27.
[19]
王灿辉,王伟,张钊,等.妥卡替尼关键中间体及其制备方法:中国,114621221A [P].2022-06-14.
[20]
阵列生物制药公司.ErbB2(HER2)抑制剂的固态分散体:中国,103998023A [P].2014-08-20.
[21]
阿雷生物药品公司.脑癌的治疗:中国,104203279A[P].2014-12-10.
[22]
阵列生物制药公司.选择性HERB2抑制剂ARRY-380的多晶型物和含有它们的药物组合物:中国,104011047A[P].2014-08-27.
[23]
张海,钟强,刘志威,等.一种妥卡替尼的制备方法:中国,112159404A [P].2021-01-01.
2023年第54卷第11期
30
8
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.11.001
  • 接收时间:2023-09-13
  • 首发时间:2026-11-19
  • 出版时间:2023-11-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-09-13
基金
作者信息
    鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400

通讯作者:

张贵民(1969—),男,研究员,从事药物研发及工程化研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.11.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏